There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Data availability:

Comments

Comment on this article

Cited by 6

Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors
Authors: Gary D. Lopaschuk, Subodh Verma
Concurrent diabetes and heart failure: interplay and novel therapeutic approaches
Authors: Qutuba Karwi, Kim Ho, Simran Pherwani …
Are the Cardiorenal Benefits of SGLT2 Inhibitors Due to Inhibition of the Sympathetic Nervous System? ∗
Authors: Subodh Verma

See all cited by

Empagliflozin increases cardiac energy production in diabetes novel translational insights into the heart failure benefits of SGLT2 inhibitors

Read this article at

Related collections

Preventive and Emergency Medicine Insights

Comments

Comment on this article

Similar content 669

Cited by 6